e-learning
resources
Munich 2014
Monday, 08.09.2014
ICU outcomes, sepsis and infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of amino-terminal pro-brain natriuretic peptide (NT-proBNP in clinical evaluation of patient with acute exacerbation chronic obstructive pulmonary disease
L. Shaaban, A. Mohamed, H. Mohamed (Assiut, Egypt)
Source:
International Congress 2014 – ICU outcomes, sepsis and infections
Session:
ICU outcomes, sepsis and infections
Session type:
Thematic Poster Session
Number:
2070
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Shaaban, A. Mohamed, H. Mohamed (Assiut, Egypt). The role of amino-terminal pro-brain natriuretic peptide (NT-proBNP in clinical evaluation of patient with acute exacerbation chronic obstructive pulmonary disease. Eur Respir J 2014; 44: Suppl. 58, 2070
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Lane-hamilton syndrome and CCF: a fatal association
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure.
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
Pro-adrenomedullin and pro-endothelin-1 for assessment and prognosis of acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 39s
Year: 2007
High urea levels predict long term mortality in patients hospitalised for acute exacerbation of COPD
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014
Brtain natriuretic peptide in chronic obstructive pulmonary disease under stable state and respiratory failure
Source: Eur Respir J 2003; 22: Suppl. 45, 269s
Year: 2003
The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Evaluation of mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease?
Source: International Congress 2014 – Comorbidities
Year: 2014
Effect of basic therapy of chronic obstructive pulmonary disease on the clinical course of acute myocardial infarction
Source: International Congress 2014 – Comorbidities
Year: 2014
Acute phase reactants as predictors for hospital mortality in acute respiratory failure due to COPD exacerbation
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
BNP level in patients with COPD exacerbations
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patient with acute exacerbations (AE) of COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Predictors of failure of noninvasive ventilation (NIV) in acute respiratory failure due to chronic obstructive pulmonary disease
Source: Annual Congress 2013 –NIV in the acute setting: growing experience and novel applications
Year: 2013
Evaluation of risk factors of ventilator associated pneumonia on outcome of acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014
NT-proBNP accurately reflects the impact of severe COPD exacerbation on the right ventricle (RV)
Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Year: 2013
Are re-admissions with acute exacerbation of chronic obstructive pulmonary disease coded correctly?
Source: International Congress 2014 – COPD exacerbations
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept